Skip to main content
All lobbying clients

ASTRAZENECA PHARMACEUTICALS LP

Lobbying client · Delaware · filed 2025 to 2026

$9,060,000 Reported spend
6 Filings counted
1 Firms hired
20 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (158571), not by name.

 Firms hired 1
 Bills named in these filings 20
  • HR 1414
    Cameron’s Law
    6 filings
  • HR 591
    Defending American Jobs and Investment Act
    6 filings
  • HR 946
    ORPHAN Cures Act
    6 filings
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    5 filings
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
    5 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    3 filings
  • HR 2423
    Unfair Tax Prevention Act
    3 filings
  • HR 4132
    Prescription Information Modernization Act of 2025
    3 filings
  • S 998
    Medical Supply Chain Resiliency Act
    3 filings
  • HR 6166
    Lowering Drug Costs for American Families Act
    2 filings
  • S 1605
    International Competition for American Jobs Act
    2 filings
  • HR 1503
    Prescription Information Modernization Act of 2023
    1 filing
  • HR 4695
    Unfair Tax Prevention Act
    1 filing
  • HR 1911
    To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subjec…
    1 filing
  • HR 3521
    Clinical Trial Modernization Act
    1 filing
  • HR 5509
    Safe Step Act
    1 filing
  • HR 7118
    Genomic Answers for Children’s Health Act of 2026
    1 filing
  • HR 9599
    SECURE 340B Act
    1 filing
  • S 1639
    American Innovation and Jobs Act
    1 filing
  • S 3841
    Last Sale Valuation Act of 2026
    1 filing
 Reported by year 2 years
  • 2026 $3,960,000 2 filings
  • 2025 $5,100,000 4 filings
 Issues lobbied 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 12
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • U.S. Trade Representative (USTR) 6
  • Centers For Medicare and Medicaid Services (CMS) 5
  • White House Office 5
  • Commerce, Dept of (DOC) 4
  • Health Resources & Services Administration (HRSA) 3
  • Bureau of Industry and Security (BIS) 2
  • Intl Trade Administration (ITA) 2
  • Health & Human Services, Dept of (HHS) 1
  • Labor, Dept of (DOL) 1
  • Treasury, Dept of 1
 Recent filings 6 total
Q2
ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $1,680,000 expenses · posted Jul 20, 2026
View → Q1
ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $2,280,000 expenses · posted Apr 20, 2026
View → Q4
ASTRAZENECA PHARMACEUTICALS LP
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $670,000 expenses · posted Jan 20, 2026
View → Q3
ASTRAZENECA PHARMACEUTICALS LP
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $1,350,000 expenses · posted Oct 17, 2025
View → Q2
ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $1,840,000 expenses · posted Jul 21, 2025
View → Q1
ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $1,240,000 expenses · posted Apr 21, 2025
View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem